|
Sample Prep for Complex Matrices - creams etc?
|
|
1
|
184
|
October 10, 2025
|
|
Monitoring the Concentration of Nitrogen Oxides in the Fluidized Bed Drying/Granulation Process and Evaluation of Reduction Methods
|
|
2
|
521
|
September 28, 2025
|
|
A Simple and Scalable Synthesis of N-Nitroso Salbutamol Impurities A, D, and F -Pub
|
|
1
|
169
|
September 27, 2025
|
|
Modeling the Impact of Excipients Selection on Nitrosamine Formation towards Risk Mitigation
|
|
18
|
5262
|
September 20, 2025
|
|
Nitrosamines risk in cleaning validation approach
|
|
11
|
388
|
September 4, 2025
|
|
N-nitrosamines: in silico modelling of DNA reactivity and identification of metabolic precursors
|
|
0
|
169
|
August 12, 2025
|
|
Estimation of bioavailable concentration of endogenously formed N-nitrosamines by physiologically based kinetic modelling
|
|
1
|
166
|
August 7, 2025
|
|
Nitrosamine Formation with Lidocaine in Ointments and Injections
|
|
1
|
439
|
August 5, 2025
|
|
Synthesis of Nitroso Derivatives of Dihydropyridine Calcium Channel Blockers
|
|
5
|
705
|
July 31, 2025
|
|
Alignment between Duplex Sequencing and transgenic rodent mutation assay data in the assessment of in vivo NDMA-induced mutagenesis-Pub
|
|
0
|
147
|
July 21, 2025
|
|
Can anybody have scientific rationale about the non formation of N-nitroso-amlodipine
|
|
3
|
697
|
July 18, 2025
|
|
Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cells -Pub
|
|
0
|
275
|
July 12, 2025
|
|
Analytical Method Development Strategy for Controlling Two New Nitrosamine Drug Substance Related Impurities (NDSRIs) in a Pharmaceutical Drug Product for Treatment of a Rare Disease -Pub
|
|
0
|
130
|
June 25, 2025
|
|
N-Nitroso Phenylephrine and N-Nitroso Phenylephrone
|
|
1
|
303
|
June 25, 2025
|
|
Mitigation of N-Nitrosamine Formation in Ranitidine Hydrochloride by Spray Drying Co-Precipitation with Mannitol, Dextrin, and Antioxidant-Pub
|
|
0
|
147
|
June 21, 2025
|
|
Atmospheric Formation of Nitrosamines in Seoul, Korea
|
|
0
|
236
|
June 9, 2025
|
|
New Paper: Impact of antioxidant addition on drug dissolution: Implications for NDSRI mitigation biowaivers
|
|
1
|
308
|
June 5, 2025
|
|
Comparative DNA damage induced by 8 nitrosamines in primary human and macaque hepatocytes -Pub
|
|
1
|
151
|
May 27, 2025
|
|
N-nitroso Torasemide Impurity formation and control
|
|
33
|
2665
|
May 27, 2025
|
|
Optimizing the detection of N-nitrosamine mutagenicity in the Ames test -Pub
|
|
17
|
828
|
May 23, 2025
|
|
Metformin and nitrosation of guanidines
|
|
8
|
534
|
May 21, 2025
|
|
Using the relative potency comparison approach, Powley et al have demonstrated the safety of NTTP exposures at or above levels of 1500 ng/day
|
|
2
|
385
|
May 17, 2025
|
|
Nitrate and nitrite food composition database: an update and extensive deep dive
|
|
2
|
348
|
May 14, 2025
|
|
HESI GTTC ring trial: Concordance between Ames and rodent carcinogenicity outcomes for N-nitrosamines (NAs) with rat and hamster metabolic conditions -Pub
|
|
0
|
129
|
May 13, 2025
|
|
NitrosAMIDES - Should they be treated the same as Nitrosamines?
|
|
3
|
1016
|
May 7, 2025
|
|
Understanding Aqueous Nitrosation Kinetics of 4-Substituted Piperidines To Risk Assess Pharmaceutical Processes and Products-Pub
|
|
1
|
256
|
May 6, 2025
|
|
Interferencia de matriz para cuantificación de NDBA
|
|
0
|
89
|
May 5, 2025
|
|
🇰🇷 Korea NRA on 'Case Studies on Reducing Impurities in Pharmaceuticals (focusing on NDMA)"
|
|
0
|
349
|
May 1, 2025
|
|
Industrial Case Studies Demonstrating Applicability of ICH M7Control Options 3 and 4 for Nitrosamine Control -Pub
|
|
4
|
787
|
April 22, 2025
|
|
Published Article: Tale of Three N-Nitrosamines and the Variables Needed to Assess Their Carcinogenicity In Silico Incorporated into a Single Workflow
|
|
0
|
200
|
April 22, 2025
|